ecrin-mdr-crcClinical2004Metastatic Colorectal CancerColorectal cancerColorectal NeoplasmsMetastatic Colorectal CancerColorectal CancerColorectal NeoplasmsInterventionalhttps://newmdr.ecrin.org/Study/20235529IrinotecanOxaliplatinCapecitabineCetuximabECRIN MDRCompletedfalseCap/Iri Plus Cetuximab Compared to Cap/ox Plus Cetuximab in Patients With Metastatic Colorectal Cancer.A randomized phase II-study to evaluate the safety and efficacy of capecitabine plus irinotecan plus cetuximab compared to capecitabine plus oxaliplatin plus cetuximab in first-line treatment of patients with metastatic colorectal cancer.2004-09-152023552NCT00254137